- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04933786
Digital Health Nudging in Adolescents With Congenital Heart Disease
January 2, 2023 updated by: Deutsches Herzzentrum Muenchen
Digital Health Nudging - Daily Smartphone Messages to Increase Physical Activity in Adolescents With Congenital Heart Disease
In adolescents with congenital heart disease physical activity level is reduced which is why promotion to a more active lifestyle with an age-appropriate and modern intervention is needed.
In healthy subjects digital health nudging was shown to increase physical activity.
However, in adolescents with congenital heart disease such studies have not been conducted yet.
In this RCT participants receive daily, short smartphone messages with the primary purpose to increase daily physical activity, which is monitored with a "Garmin vivofit jr." wearable.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
97
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bavaria
-
Munich, Bavaria, Germany, 80636
- Department of Congenital Heart Defects and Pediatric Cardiology, German Heart Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adolescents aged 12 to 18 years inclusive
- Presence of a congenital heart defect (must be moderate or complex according to ACC criteria)
- Presence of written informed consent
Exclusion Criteria:
- Cognitive impairments that inhibit patients from understanding the tasks
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Digital Health Nudging
During 12-week intervention period participants receive daily text messages via WhatsApp on their smartphone to encourage them to be physically active in their daily lives.
|
Short daily text messages with information and motivation concerning physical activity.
|
|
No Intervention: Control
During 12-week control period participants receive no text messages.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Objectively measured physical activity
Time Frame: 25 weeks
|
Physical activity is objectively assessed with the wrist worn wearable "Garmin vivofit jr.".
Daily physical activity is measured on the basis of active minutes in moderate-to-vigorous intensity.
|
25 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Objectively measured daily step count
Time Frame: 25 weeks
|
Daily step count is objectively assessed with the wrist worn wearable "Garmin vivofit jr.".
|
25 weeks
|
|
Activity-related self-efficacy
Time Frame: Baseline, after 12 weeks, after 24 weeks
|
Perceived self-efficacy in the context of physical activity is measured using the German version of the Physical Activity Self-Efficacy Scale.
The scale consists of eight items, each of which is answered on a five-point Likert scale.
|
Baseline, after 12 weeks, after 24 weeks
|
|
Health-related quality of life
Time Frame: Baseline, after 12 weeks, after 24 weeks
|
Health-related quality of life is self-assessed via the KINDL® questionnaire.
The KINDL® is a generic instrument for assessing health-related quality of life in children and adolescents.
The KINDL® is a short, methodologically tested and flexible measurement instrument consisting of 24 questions on the six areas of body/physis, feelings/psychology, self-assessment, family, friends and school.
|
Baseline, after 12 weeks, after 24 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Jan Müller, PD Dr.rer.nat, Technical university munich, Chair of preventive perdiatrics
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2021
Primary Completion (Actual)
November 1, 2022
Study Completion (Actual)
November 1, 2022
Study Registration Dates
First Submitted
June 14, 2021
First Submitted That Met QC Criteria
June 14, 2021
First Posted (Actual)
June 22, 2021
Study Record Updates
Last Update Posted (Actual)
January 4, 2023
Last Update Submitted That Met QC Criteria
January 2, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 265/21 S
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congenital Heart Disease
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingAdult Congenital Heart Disease | Congenital Heart Disease (CHD) | Pediatric Congenital Heart Disease | Heart Transplant PatientsItaly
-
Seoul National University HospitalUniversity of SeoulNot yet recruitingCongenital Heart Disease in Children | Congenital Heart Disease (CHD) | Complex Congenital Heart DiseaseKorea, Republic of
-
University of UlsterBelfast Health and Social Care TrustCompletedCongenital Heart Disease | Congenital Heart Defect | Adult Congenital Heart DiseaseUnited Kingdom
-
China National Center for Cardiovascular DiseasesPeking University; Shandong University; Guangxi Medical University; Wenzhou Medical... and other collaboratorsActive, not recruitingStructural Heart Disease | Congenital Heart Disease (CHD)China
-
The Children's Hospital of Zhejiang University...Beijing Children's Hospital; Children's Hospital of Nanjing Medical UniversityNot yet recruitingCongenital Heart Disease in Children | Congenital Heart Disease (CHD)China
-
Martin SchweigerUniversity Children's Hospital, ZurichRecruitingFontan Physiology | Congenital Heart Disease in Children | Congenital Heart SurgerySwitzerland
-
Children's Hospital Medical Center, CincinnatiNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Disease CongenitalUnited States
-
University Hospital, BordeauxNot yet recruitingCHD - Congenital Heart DiseaseFrance
-
Leiden University Medical CenterRecruitingAdult Congenital Heart DiseaseNetherlands
-
Cairo UniversityNot yet recruiting
Clinical Trials on Digital Health Nudging
-
Alexandra HospitalNational University of SingaporeRecruitingHypertension | Hyperlipidemia | Prediabetes | Elevated Blood Pressure | Type 2 Diabetes Mellitus (T2DM) | Overweight/ObesitySingapore
-
LirioCone HealthRecruiting
-
Istanbul Gelisim UniversityNot yet recruitingObesity Prevention | Unhealthy Diet | Non-Communicable Chronic Diseases | Dietary Behaviour | Ultra-Processed Food Consumption
-
Bispebjerg HospitalRecruitingPhysical Activity | Digital Health | InpatientsDenmark, Faroe Islands, Greenland
-
Bispebjerg HospitalAAL; InnovationsfondenCompletedHeart Failure | Arthritis | Parkinson Disease | Stroke Sequelae | COPD | Old Age; CachexiaDenmark
-
McMaster UniversityTerminatedPeripheral Arterial DiseaseCanada
-
Rio de Janeiro State UniversityOswaldo Cruz FoundationCompleted
-
Medisch Spectrum TwenteCatharina Ziekenhuis Eindhoven; St. Antonius Hospital; Onze Lieve Vrouwe Gasthuis and other collaboratorsRecruiting
-
University of OsloCompletedIntellectual Disability | Intellectual Disabilities NutritionalNorway
-
Pack HealthGlaxoSmithKline; University of WashingtonRecruitingMultiple Myeloma | Relapsed Hematologic MalignancyUnited States